Explore evidence

14 %Infection with Schistosoma mansoni was associated with a 14% higher estimated proportion of active TB cases in HIV-infected individuals.

Kenyatuberculoseobserved 2014 and 2017published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 2 observations

8.3 %Among HIV-infected patients in Central Kenya, those on TB treatment during their last known visit decreased from 8.3% in 2004 to 3.9% in 2014.

Kenyatuberculose · VIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

95.6 %GeneXpert sensitivity in smear positive culture positive specimens was 95.6%, compared to 97.2% for ZN microscopy and 97.2% for LED fluorescent microscopy.

Kenyatuberculoseobserved 2013-2014published 2019African Journal of Health SciencesOpenAlexdocument of 6 observations

35 %Tuberculosis/HIV coinfection rate was 35% among the cohort of 291 patients in Vihiga County.

Kenyatuberculose · VIH/sidapublished 2023African health sciencesPubMeddocument of 6 observations

0.4 %Among HIV-positive tuberculosis patients in Western Kenya, INH + KAN polyresistant strains occurred in 0.4% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

79 %During SLATE II, 79% of patients with ≥1 tuberculosis (TB) symptom were tested for TB.

Kenyatuberculoseobserved SLATE IIpublished 2020BMJ openPubMeddocument of 12 observations

16.4 %Resistance to rifampicin (RIF) among HIV-negative tuberculosis patients in Western Kenya was 16.4%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

28.5 %Resistance to isoniazid (INH) among HIV-negative tuberculosis patients in Western Kenya was 28.5%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

0.3 %Capreomycin resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

56.7 %Sputum smear microscopy (SSM) registered a sensitivity of 56.7% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobserved 2022-2023published 2024PloS onePubMeddocument of 7 observations

35.2 CqAmong participants with tuberculosis, mean oral swab threshold quantitation cycle value was 35.2 at enrollment visit.

Kenyatuberculosepublished 2022PloS onePubMeddocument of 10 observations

29 casesTwenty-nine women were diagnosed with tuberculosis.

Kenyatuberculoseobserved between March 2000 and January 2010published 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0000000000001461

4.3 %Among TB patients, 4.3% were lost to follow-up.

Kenyatuberculoseobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

26.3 %Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%).

Kenyatuberculosepublished 2026The Journal of infectious diseasesPubMeddocument of 4 observations

99 %Uptake of cotrimoxazole prophylaxis among TB/HIV co-infected patients was 99%.

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

0.3 %Ethionamide resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

5.7 %Scedosporium spp. were isolated from 5 out of 88 fungal-positive sputum samples (5.7%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

96.4 %Among children and adolescents living with HIV in central Kenya, 96.4% did not have tuberculosis symptoms.

Kenyatuberculose · VIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

98 %Among children living with HIV aged <15 years newly enrolled in HIV care in eight HIV clinics in western Kenya, 98% (n = 841) underwent screening for TB symptoms and IPT eligibility between September 2015 and July 2019.

Kenyatuberculoseobserved September 2015 through July 2019published 2022Journal of the International AIDS SocietyPubMeddocument of 7 observations

2.4 hazard_ratioHIV infection was associated with a 2.40-fold higher hazard of death during TB treatment compared to HIV-negative status.

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

26.6 %The number of notified tuberculosis cases decreased by 26.6% during the pandemic onset in Kenya.

Kenyatuberculosepublished 2022The Lancet. Global healthPubMeddocument of 12 observations

62 individualsAmong 152 children with HIV, 40.8% (62) were tuberculosis–antiretroviral therapy treated.

Kenyatuberculose · VIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations

84.5 %Sputum smear microscopy (SSM) recorded a positive predictive value of 84.5% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobserved 2022-2023published 2024PloS onePubMeddocument of 7 observations

155 assaysNinety-seven infants had 155 urine isoniazid metabolite assays performed in an infant tuberculosis prevention trial in Kenya.

Kenyatuberculosepublished 2021The Pediatric infectious disease journalPubMeddocument of 2 observations

18.4 %Out of the 37 (18.4%) who returned for follow up at 2 weeks, none was either sputum smear positive or Gene-Xpert positive.

Kenyatuberculoseobserved February 2013 to February 2014published 2019African Journal of Health SciencesOpenAlexdocument of 5 observations